Meet OPEN Health and Pharmerit Experts at the World Orphan Drug Virtual USA Congress

Written by Candice Subero on Thursday 20th August 2020

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:

Advanced Therapies Commercial: Tuesday, August 25
Succeeding with Star Wars Medicine: Translating the Science and Value of Gene Therapy to Key Stakeholders

Gavin Jones, Director of Rare Disease, OPEN Health

PANEL: Wednesday, August 26
Bridging the Clinical Evidence Gap for Payers – Examining Recent Cases of Real-World Evidence for Reimbursement

Shelby Corman, Real-World Evidence and Data Analytics Lead, Pharmerit

Pink divider

OPEN Health is the only integrated agency that combines the depth of rare disease knowledge with the breath of discipline expertise across medical affairs, commercial, HEOR and market access.

OPEN Health’s Evidence and Access practice is a best in class global HEOR and market access consultancy that specialises in identifying client critical issues and building bespoke integrated solutions to support companies operating in rare disease and improve patient outcomes.

The Patient and Brand Communications practice at OPEN Health combines a deep focus in patient engagement (patient journey mapping and patient support programmes), PR (brand, disease awareness, corporate and internal communications) and advertising.

The Medical Communications practice provides expertise in Medical Affairs content and consultancy, publication planning and management, medical education, and internal training.

In addition to extensive rare disease experience we have delivered projects for over half the advanced therapies that have been launched in the United States and Europe.

Pink divider

Our executive team will be available to speak with you regarding how OPEN Health and Pharmerit can support you in the fight against rare diseases. Contact Gavin Jones today to set up a meeting.

Read the follow up article here.